analysts news from FiercePharma
News
E&Y: Pharma neglects working capital
Could Big Pharma ease some of its ills if it just managed itself better? Ernst & Young says drugmakers could free up to $35 billion in working capital just by improving their management of... Read more...
Analysts get bullish on generics makers
The flip side of Big Pharma's angst over generic competition is growing exuberance about generics makers. Early this week, the Wall... Read more...
Merck expects $1.8B hit on Fosamax
We all knew that losing patent protection on Fosamax would cut into Merck's sales next year. We just didn't know how much. Now we do, or at least we know Merck's best estimate: about $1.8 billion.... Read more...
BMS starts laying off workers
The ax is starting to fall at Bristol-Myers Squibb. The company has started notifying employees that... Read more...
AZ may cut supplies to boost returns
That Crestor patent challenge is coming home to roost. AstraZeneca... Read more...
BMS to unveil layoffs, manufacturing cuts
Will Bristol-Myers Squibb join the layoff parade Read more...
Analyst: AZ "worst performer" in pharma
So, Dresdner Kleinwort, tell us how you really feel about AstraZeneca. The investment bank, which just started covering AstraZeneca's stock, minced no words in its first report. The company's in... Read more...
Bristol CEO: Job cuts, shutdowns continue
It's a layoffs kind of news day. Bristol-Myers Squibb CEO James Cornelius announced that job cuts have begun at the drug maker, and will continue through year's end and into 2008. Facilities will be... Read more...
Boston Scientific preps for big layoffs
Welcome to the wake, Boston Scientific. The device maker is poised to join its healthcare colleagues in laying off... Read more...
Pharma execs practice positive thinking
Throw a bunch of pharma execs into a room with financial analysts, and what do you get? Almost unmitigated hope. Thinking positive is a must when analysts are around, so as industry leaders stand up... Read more...
Get more analysts coverage at:
Paid Research Reports
- Leading Drug Delivery Companies and Technologies: Competitive landscape, company profiles and technological developments
- Drug Repositioning Strategies - Serendipity by design
- eHealthInsight Series: Online Patient Recruitment Strategies - Optimizing the clinical trial process
- Pricing & Reimbursement - Seven Major Markets Update
- Innovative Clinical Trial Design and Management: Trends, success stories and impact upon R&D budgets
